Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05416437 · ClinicalTrials.gov registry record · NA
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
A NA study of Dyspnea, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05416437: Active NA study of Dyspnea, sponsored by Ohio State University.
NCT05416437 is a NA study of Dyspnea that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 80 participants, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05416437, a NA study of Dyspnea, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The BREATHE-easy is a randomized control trial assessing the efficacy of the novel PneumoCool device to alleviate subjective shortness of breath. The PneumoCool device is a disposable, bladeless, highly portable device that uses medical-grade air that confers many advantages in a hospital setting.
Primary Outcome
Mean changes in the Borg Dyspnea scale (0 indicating no effort of breathing, 10 indicating maximal effort of breathing)
Conditions Studied
Interventions
- DEVICE PneumoCool
- OTHER Current supportive measures that are used in the hospital for standard of care
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the registry record for NCT05416437 still lists
NCT05416437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Dyspnea appearing as the primary indexed condition, and to 2 interventions - of which PneumoCool is the first listed.
NCT05416437 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05416437 about?
NCT05416437 is a clinical study titled "Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience". The BREATHE-easy is a randomized control trial assessing the efficacy of the novel PneumoCool device to alleviate subjective shortness of breath. The PneumoCool device is a disposable, bladeless, highly portable device that uses medical-grade air that confers many advantages in a hospital setting.
What is the current status of trial NCT05416437?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-06-15. Estimated completion is 2025-06-30.
What conditions does trial NCT05416437 study?
This clinical trial studies the following conditions: Dyspnea.
What interventions are being tested in trial NCT05416437?
The interventions under investigation include: PneumoCool (DEVICE), Current supportive measures that are used in the hospital for standard of care (OTHER).
Who is sponsoring clinical trial NCT05416437?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05416437 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05416437's enrollment target sits among peer trials
80 11th of 23 higher than 13 of 23 other Dyspnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
-
Improving Management of Breathlessness in Patients With Lung Cancer
COMPLETED · NA
-
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
COMPLETED · NA
-
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
COMPLETED · NA
-
Improving Care of Patients With Heart Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI